Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study
Walter Reinisch, Williem de Villiers, László Bene, László Simon, István Rácz, Seymour Katz, István Altorjay, Brian Feagan, Dennis Riff, Charles N. Bernstein, Daniel Hommes, Paul Rutgeerts, Antoine CorVolume:
16
Année:
2010
Langue:
english
Pages:
1
DOI:
10.1002/ibd.21038
Fichier:
PDF, 285 KB
english, 2010